| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.578 | 0.001 | 0.578 | Aldosterone antagonist | 0.364 0.002 DBMET03393 0.047 0.033 DBMET03394 0.152 0.005 DBMET03395 0.181 0.004 DBMET03398 0.187 0.004 DBMET03399 0.051 0.028 DBMET03396 0.069 0.015 DBMET03400 0.073 0.013 DBMET03397 0.114 0.007 DBMET03401 | ||
| 0.538 | 0.012 | 0.538 | Cardiotonic | 0.469 0.019 DBMET03393 0.208 0.111 DBMET03395 0.471 0.018 DBMET03398 0.285 0.063 DBMET03399 0.224 0.099 DBMET03400 0.24 0.09 DBMET03401 | ||
| 0.424 | 0.017 | 0.424 | Calcium channel activator | 0.392 0.028 DBMET03393 0.216 0.19 DBMET03394 0.238 0.161 DBMET03395 0.29 0.102 DBMET03398 0.216 0.19 DBMET03396 0.236 0.164 DBMET03397 | ||
| 0.443 | 0.055 | 0.52 | Calcium channel L-type activator | 0.453 0.049 DBMET03393 0.452 0.05 DBMET03395 0.52 0.021 DBMET03398 0.492 0.031 DBMET03396 0.292 0.164 DBMET03400 0.471 0.04 DBMET03397 0.244 0.212 DBMET03401 | DBMET03398 | |
| 0.35 | 0.016 | 0.35 | Diuretic | 0.167 0.063 DBMET03393 0.269 0.028 DBMET03398 | ||
| 0.345 | 0.035 | 0.405 | Vasodilator | 0.304 0.047 DBMET03393 0.273 0.058 DBMET03394 0.405 0.022 DBMET03398 0.155 0.15 DBMET03399 0.177 0.124 DBMET03396 0.174 0.128 DBMET03400 0.173 0.128 DBMET03397 0.17 0.131 DBMET03401 | DBMET03398 | |
| 0.215 | 0.004 | 0.215 | Mineralocorticoid receptor antagonist | 0.188 0.004 DBMET03393 0.056 0.023 DBMET03395 0.135 0.005 DBMET03398 0.094 0.009 DBMET03399 0.075 0.013 DBMET03400 0.052 0.028 DBMET03397 0.086 0.01 DBMET03401 | ||
| 0.259 | 0.087 | 0.398 | Ca(v)3.3 blocker | 0.209 0.172 DBMET03393 0.398 0.005 DBMET03394 0.258 0.089 DBMET03395 0.221 0.15 DBMET03399 0.206 0.179 DBMET03396 0.198 0.195 DBMET03397 | DBMET03394 | |
| 0.18 | 0.016 | 0.18 | Calcium antagonist | 0.073 0.07 DBMET03393 0.072 0.071 DBMET03398 | ||
| 0.173 | 0.043 | 0.173 | Calcium channel blocker | |||
| 0.159 | 0.057 | 0.181 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.181 0.031 DBMET03393 0.156 0.063 DBMET03395 0.16 0.055 DBMET03398 0.133 0.108 DBMET03399 0.142 0.089 DBMET03396 0.178 0.034 DBMET03397 0.156 0.062 DBMET03401 | DBMET03393 | |
| 0.168 | 0.07 | 0.175 | Catenin beta inhibitor | 0.143 0.122 DBMET03393 0.139 0.136 DBMET03395 0.175 0.058 DBMET03398 0.16 0.083 DBMET03397 0.143 0.124 DBMET03401 | DBMET03398 | |
| 0.154 | 0.069 | 0.188 | CF transmembrane conductance regulator agonist | 0.172 0.044 DBMET03393 0.175 0.041 DBMET03399 0.188 0.03 DBMET03400 0.148 0.08 DBMET03401 | DBMET03400 | |
| 0.227 | 0.147 | 0.227 | Vasodilator, peripheral | 0.206 0.169 DBMET03394 0.211 0.164 DBMET03398 | ||
| 0.11 | 0.039 | 0.148 | Androgen antagonist | 0.148 0.023 DBMET03393 0.101 0.046 DBMET03398 | DBMET03393 | |
| 0.092 | 0.029 | 0.092 | Calcium channel L-type blocker | |||
| 0.196 | 0.135 | 0.234 | MAP kinase kinase 3 inhibitor | 0.207 0.104 DBMET03393 0.19 0.155 DBMET03394 0.234 0.05 DBMET03395 0.207 0.104 DBMET03399 0.217 0.08 DBMET03396 0.194 0.139 DBMET03400 0.213 0.089 DBMET03397 0.191 0.151 DBMET03401 | DBMET03395 | |
| 0.049 | 0.007 | 0.05 | Transforming growth factor beta 2 antagonist | 0.05 0.007 DBMET03393 0.034 0.021 DBMET03398 | DBMET03393 | |
| 0.097 | 0.06 | 0.107 | DNA directed RNA polymerase inhibitor | 0.094 0.063 DBMET03393 0.091 0.067 DBMET03394 0.107 0.049 DBMET03398 | DBMET03398 | |
| 0.158 | 0.122 | 0.161 | MAP kinase kinase 5 inhibitor | 0.152 0.146 DBMET03393 0.161 0.113 DBMET03395 | DBMET03395 | |
| 0.12 | 0.084 | 0.201 | Sodium channel (voltage-gated) blocker | 0.158 0.049 DBMET03394 0.201 0.029 DBMET03395 0.116 0.089 DBMET03396 | DBMET03395 | |
| 0.094 | 0.061 | 0.094 | Toll-Like receptor 3 antagonist | |||
| 0.247 | 0.216 | 0.44 | Cyclophilin D inhibitor | 0.44 0.071 DBMET03398 0.326 0.141 DBMET03396 0.307 0.157 DBMET03397 | DBMET03398 | |
| 0.075 | 0.046 | 0.092 | MAP3K7 inhibitor | 0.092 0.028 DBMET03395 0.08 0.04 DBMET03396 0.068 0.059 DBMET03397 | DBMET03395 | |
| 0.088 | 0.064 | 0.088 | Antiadrenergic | 0.084 0.067 DBMET03393 | ||
| 0.085 | 0.064 | 0.085 | Adrenaline antagonist | 0.082 0.066 DBMET03393 | ||
| 0.081 | 0.06 | 0.099 | Transforming growth factor beta 3 antagonist | 0.081 0.061 DBMET03393 0.099 0.024 DBMET03394 | DBMET03394 | |
| 0.25 | 0.233 | 0.336 | MAP kinase 1 inhibitor | 0.278 0.204 DBMET03393 0.336 0.146 DBMET03395 0.255 0.227 DBMET03399 | DBMET03395 | |
| 0.246 | 0.233 | 0.268 | 5 Hydroxytryptamine release inhibitor | 0.268 0.204 DBMET03397 | DBMET03397 | |
| 0.063 | 0.05 | 0.063 | Beta adrenoreceptor antagonist | |||
| 0.104 | 0.098 | 0.135 | Tubulin antagonist | 0.135 0.067 DBMET03393 | DBMET03393 | |
| 0.103 | 0.102 | 0.222 | Phosphodiesterase inhibitor | 0.222 0.029 DBMET03395 0.185 0.039 DBMET03396 0.169 0.047 DBMET03397 | DBMET03395 | |
| 0.027 | 0.033 | 0.04 | Progesterone antagonist | 0.04 0.022 DBMET03393 | DBMET03393 | |
| 0.06 | 0.066 | 0.075 | I kappa B kinase 1 inhibitor | 0.075 0.042 DBMET03395 | DBMET03395 | |
| 0.058 | 0.067 | 0.099 | Phosphodiesterase 5A inhibitor | 0.098 0.028 DBMET03395 0.099 0.027 DBMET03396 0.083 0.037 DBMET03397 | DBMET03396 | |
| 0.056 | 0.065 | 0.108 | Nav1.7 sodium channel blocker | 0.108 0.02 DBMET03395 | DBMET03395 | |
| 0.074 | 0.09 | 0.103 | Check point kinase 2 inhibitor | 0.103 0.062 DBMET03393 0.084 0.08 DBMET03395 | DBMET03393 | |
| 0.055 | 0.072 | 0.098 | Phosphodiesterase V inhibitor | 0.095 0.03 DBMET03395 0.098 0.028 DBMET03396 0.081 0.04 DBMET03397 | DBMET03396 | |
| 0.016 | 0.047 | 0.031 | Glucocorticoid antagonist | 0.031 0.023 DBMET03399 | DBMET03399 | |
| 0.052 | 0.084 | 0.081 | Histone deacetylase SIRT2 inhibitor | 0.081 0.045 DBMET03395 0.071 0.054 DBMET03396 | DBMET03395 | |
| 0.074 | 0.11 | 0.094 | Granulocyte macrophage colony stimulating factor antagonist | 0.094 0.08 DBMET03395 | DBMET03395 | |
| 0.086 | 0.121 | 0.099 | Electron transport complex I inhibitor | 0.099 0.085 DBMET03395 | DBMET03395 | |
| 0.039 | 0.077 | 0.066 | Protein kinase C theta inhibitor | 0.066 0.027 DBMET03395 0.055 0.044 DBMET03396 | DBMET03395 | |
| 0.034 | 0.076 | 0.056 | H+/K+-transporting ATPase inhibitor | 0.056 0.029 DBMET03394 0.052 0.035 DBMET03395 | DBMET03394 | |
| 0.087 | 0.135 | 0.194 | Sodium channel blocker | 0.187 0.037 DBMET03394 0.194 0.035 DBMET03395 | DBMET03395 | |
| 0.167 | 0.216 | 0.228 | Vasodilator, coronary | 0.228 0.156 DBMET03398 | DBMET03398 | |
| 0.068 | 0.12 | 0.088 | MAP kinase 8 inhibitor | 0.088 0.075 DBMET03395 | DBMET03395 | |
| 0.049 | 0.106 | 0.256 | Phosphodiesterase IV inhibitor | 0.111 0.038 DBMET03394 0.23 0.009 DBMET03395 0.249 0.008 DBMET03396 0.256 0.007 DBMET03397 | DBMET03397 | |
| 0.047 | 0.106 | 0.063 | Phosphodiesterase 1C inhibitor | 0.058 0.055 DBMET03395 0.063 0.041 DBMET03396 | DBMET03396 | |
| 0.038 | 0.099 | 0.06 | HIV-1 reverse transcriptase inhibitor | 0.06 0.058 DBMET03393 | DBMET03393 | |
| 0.11 | 0.184 | 0.136 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.136 0.128 DBMET03395 | DBMET03395 | |
| 0.11 | 0.192 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.116 DBMET03393 | DBMET03393 | |
| 0.073 | 0.157 | 0.119 | Activin receptor-like kinase 4 inhibitor | 0.119 0.053 DBMET03395 | DBMET03395 | |
| 0.069 | 0.156 | 0.104 | Lck kinase inhibitor | 0.104 0.099 DBMET03395 | DBMET03395 | |
| 0.072 | 0.161 | 0.105 | Nav1.5 sodium channel blocker | 0.105 0.077 DBMET03394 0.096 0.092 DBMET03395 | DBMET03394 | |
| 0.104 | 0.194 | 0.153 | P-glycoprotein inhibitor | 0.153 0.112 DBMET03399 0.145 0.125 DBMET03400 0.147 0.122 DBMET03401 | DBMET03399 | |
| 0.025 | 0.118 | 0.036 | Vanilloid 3 antagonist | 0.036 0.034 DBMET03394 0.036 0.035 DBMET03395 | DBMET03395 | |
| 0.059 | 0.156 | 0.088 | Bromodomain-containing protein 2 inhibitor | 0.088 0.059 DBMET03395 | DBMET03395 | |
| 0.034 | 0.136 | 0.101 | Transcription factor AP-1 inhibitor | 0.069 0.031 DBMET03398 0.101 0.013 DBMET03397 0.068 0.033 DBMET03401 | DBMET03397 | |
| 0.051 | 0.154 | 0.08 | Protein kinase C delta inhibitor | 0.08 0.076 DBMET03396 | DBMET03396 | |
| 0.056 | 0.16 | 0.087 | Phosphodiesterase XI inhibitor | 0.087 0.046 DBMET03395 | DBMET03395 | |
| 0.056 | 0.16 | 0.087 | Phosphodiesterase 11A inhibitor | 0.087 0.046 DBMET03395 | DBMET03395 | |
| 0.032 | 0.137 | 0.226 | Phosphodiesterase 4B inhibitor | 0.167 0.01 DBMET03395 0.18 0.009 DBMET03396 0.226 0.006 DBMET03397 | DBMET03397 | |
| 0.032 | 0.142 | 0.046 | Sodium/calcium exchanger inhibitor | 0.046 0.044 DBMET03394 | DBMET03394 | |
| 0.047 | 0.165 | 0.129 | Protein kinase (CK2) alpha inhibitor | 0.129 0.056 DBMET03397 | DBMET03397 | |
| 0.018 | 0.136 | 0.126 | Xanthine dehydrogenase inhibitor | 0.052 0.044 DBMET03395 0.068 0.033 DBMET03398 0.079 0.025 DBMET03396 0.126 0.01 DBMET03397 | DBMET03397 | |
| 0.038 | 0.157 | 0.085 | Acetylcholine M3 receptor agonist | 0.085 0.055 DBMET03394 | DBMET03394 | |
| 0.14 | 0.26 | 0.188 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.188 0.172 DBMET03393 | DBMET03393 | |
| 0.037 | 0.157 | 0.062 | Orexin receptor antagonist | 0.062 0.053 DBMET03395 | DBMET03395 | |
| 0.009 | 0.142 | 0.066 | Glutamate (mGluR2) agonist | 0.066 0.01 DBMET03396 0.033 0.022 DBMET03400 | DBMET03396 | |
| 0.012 | 0.147 | 0.07 | Glutamate (mGluR group II) agonist | 0.07 0.01 DBMET03396 0.037 0.023 DBMET03400 | DBMET03396 | |
| 0.017 | 0.152 | 0.098 | Phosphodiesterase 4A inhibitor | 0.098 0.015 DBMET03394 | DBMET03394 | |
| 0.028 | 0.165 | 0.074 | Phosphodiesterase 4D inhibitor | 0.067 0.058 DBMET03395 0.074 0.052 DBMET03396 0.065 0.06 DBMET03397 | DBMET03396 | |
| 0.104 | 0.242 | 0.134 | CC chemokine 6 receptor antagonist | 0.123 0.099 DBMET03395 0.121 0.109 DBMET03398 0.123 0.099 DBMET03396 0.134 0.057 DBMET03397 | DBMET03397 | |
| 0.043 | 0.184 | 0.068 | Orexin receptor 1 antagonist | 0.068 0.063 DBMET03395 | DBMET03395 | |
| 0.032 | 0.175 | 0.061 | Alpha 1L adrenoreceptor antagonist | 0.061 0.021 DBMET03395 0.051 0.04 DBMET03396 0.049 0.044 DBMET03397 | DBMET03395 | |
| 0.054 | 0.199 | 0.104 | Beta glucuronidase inhibitor | 0.104 0.064 DBMET03393 | DBMET03393 | |
| 0.054 | 0.2 | 0.125 | ABCA1 expression enhancer | 0.106 0.043 DBMET03395 0.105 0.044 DBMET03396 0.125 0.027 DBMET03397 | DBMET03397 | |
| 0.044 | 0.195 | 0.086 | Gastric antisecretory | 0.086 0.084 DBMET03394 | DBMET03394 | |
| 0.032 | 0.183 | 0.073 | Potassium channel (ATP-sensitive) blocker | 0.073 0.036 DBMET03394 | DBMET03394 | |
| 0.042 | 0.194 | 0.081 | GABA A receptor agonist | 0.077 0.069 DBMET03394 0.081 0.062 DBMET03395 0.076 0.072 DBMET03396 | DBMET03395 | |
| 0.026 | 0.186 | 0.1 | Nav1.8 sodium channel blocker | 0.1 0.028 DBMET03394 | DBMET03394 | |
| 0.044 | 0.206 | 0.115 | Uric acid excretion stimulant | 0.088 0.068 DBMET03398 0.082 0.079 DBMET03396 0.115 0.041 DBMET03397 | DBMET03397 | |
| 0.135 | 0.298 | 0.243 | Antiobesity | 0.243 0.163 DBMET03398 | DBMET03398 | |
| 0.005 | 0.171 | 0.014 | Dipeptidyl peptidase IX inhibitor | 0.014 0.013 DBMET03395 | DBMET03395 | |
| 0.079 | 0.246 | 0.135 | Hepatoprotectant | 0.135 0.126 DBMET03398 | DBMET03398 | |
| 0.039 | 0.208 | 0.092 | Glycogen synthase kinase-3 beta inhibitor | 0.092 0.089 DBMET03395 | DBMET03395 | |
| 0.038 | 0.221 | 0.096 | Glycogen synthase kinase-3 inhibitor | 0.096 0.083 DBMET03395 | DBMET03395 | |
| 0.028 | 0.223 | 0.079 | MAP-kinase-activated kinase 2 inhibitor | 0.079 0.045 DBMET03395 | DBMET03395 | |
| 0.033 | 0.228 | 0.108 | Ca(v)2.2 blocker | 0.108 0.044 DBMET03394 | DBMET03394 | |
| 0.034 | 0.232 | 0.09 | MAP-kinase-activated kinase inhibitor | 0.09 0.049 DBMET03395 | DBMET03395 | |
| 0.03 | 0.228 | 0.09 | MAP kinase kinase kinase inhibitor | 0.09 0.076 DBMET03395 | DBMET03395 | |
| 0.119 | 0.321 | 0.291 | 15-Lipoxygenase inhibitor | 0.291 0.137 DBMET03393 | DBMET03393 | |
| 0.042 | 0.253 | 0.101 | M17 leucyl aminopeptidase inhibitor | 0.101 0.1 DBMET03393 | DBMET03393 | |
| 0.042 | 0.255 | 0.105 | Xanthine oxidase inhibitor | 0.105 0.056 DBMET03397 | DBMET03397 | |
| 0.013 | 0.228 | 0.048 | Dihydroorotate dehydrogenase inhibitor | 0.048 0.039 DBMET03397 | DBMET03397 | |
| 0.101 | 0.321 | 0.166 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.166 0.115 DBMET03393 | DBMET03393 | |
| 0.075 | 0.302 | 0.253 | Tumour necrosis factor alpha release inhibitor | 0.253 0.073 DBMET03394 0.213 0.098 DBMET03395 0.17 0.134 DBMET03396 | DBMET03394 | |
| 0.013 | 0.242 | 0.081 | Glutamate (mGluR) agonist | 0.081 0.03 DBMET03396 | DBMET03396 | |
| 0.059 | 0.298 | 0.2 | Potassium channel blocker | 0.2 0.093 DBMET03394 | DBMET03394 | |
| 0.033 | 0.276 | 0.113 | Histamine H2 receptor antagonist | 0.113 0.025 DBMET03394 | DBMET03394 | |
| 0.087 | 0.342 | 0.164 | Death-associated protein kinase 2 inhibitor | 0.143 0.124 DBMET03393 0.164 0.078 DBMET03395 0.143 0.122 DBMET03396 0.138 0.136 DBMET03397 | DBMET03395 | |
| 0.108 | 0.367 | 0.349 | Toll-Like receptor 7 agonist | 0.349 0.082 DBMET03394 0.203 0.197 DBMET03395 0.211 0.187 DBMET03396 | DBMET03394 | |
| 0.036 | 0.298 | 0.136 | GABA receptor agonist | 0.136 0.044 DBMET03394 | DBMET03394 | |
| 0.046 | 0.31 | 0.194 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.194 0.096 DBMET03397 | DBMET03397 | |
| 0.046 | 0.316 | 0.188 | Dyrk kinase inhibitor | 0.188 0.105 DBMET03397 | DBMET03397 | |
| 0.103 | 0.377 | 0.353 | Toll-Like receptor agonist | 0.353 0.081 DBMET03394 0.203 0.199 DBMET03395 0.217 0.182 DBMET03396 | DBMET03394 | |
| 0.028 | 0.326 | 0.105 | Bronchodilator | 0.105 0.058 DBMET03396 | DBMET03396 | |
| 0.063 | 0.366 | 0.16 | Antioxidant | 0.16 0.154 DBMET03398 | DBMET03398 | |
| 0.044 | 0.36 | 0.107 | Nav1.2 sodium channel blocker | 0.107 0.101 DBMET03394 | DBMET03394 | |
| 0.028 | 0.361 | 0.145 | AMP-activated protein kinase stimulant | 0.145 0.031 DBMET03398 | DBMET03398 | |
| 0.065 | 0.441 | 0.188 | Hypoglycemic | 0.188 0.124 DBMET03398 | DBMET03398 | |
| 0.059 | 0.443 | 0.213 | Transcription factor NF kappa B inhibitor | 0.213 0.157 DBMET03397 | DBMET03397 | |
| 0.027 | 0.415 | 0.172 | Lipid peroxidase inhibitor | 0.172 0.055 DBMET03394 | DBMET03394 | |
| 0.071 | 0.476 | 0.223 | Histamine release inhibitor | 0.223 0.178 DBMET03398 | DBMET03398 | |
| 0.062 | 0.483 | 0.152 | Lipocortins synthesis antagonist | 0.152 0.102 DBMET03401 | DBMET03401 | |
| 0.096 | 0.54 | 0.262 | Antiinflammatory | 0.262 0.253 DBMET03396 | DBMET03396 | |
| 0.005 | 0.49 | 0.039 | Liver X receptor antagonist | 0.039 0.014 DBMET03396 | DBMET03396 | |
| 0.028 | 0.519 | 0.261 | Cytokine production inhibitor | 0.223 0.03 DBMET03395 0.191 0.039 DBMET03396 0.261 0.021 DBMET03397 | DBMET03397 | |
| 0.018 | 0.51 | 0.151 | Neurotrophic factor | 0.137 0.072 DBMET03399 0.147 0.061 DBMET03400 0.151 0.058 DBMET03401 | DBMET03401 | |
| 0.026 | 0.523 | 0.21 | Interleukin antagonist | 0.21 0.079 DBMET03394 | DBMET03394 | |
| 0.024 | 0.527 | 0.099 | Acetylcholine release stimulant | 0.099 0.089 DBMET03394 | DBMET03394 | |
| 0.023 | 0.525 | 0.204 | Angiogenesis stimulant | 0.161 0.116 DBMET03399 0.204 0.092 DBMET03400 0.181 0.104 DBMET03401 | DBMET03400 | |
| 0.017 | 0.55 | 0.077 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.077 0.069 DBMET03397 | DBMET03397 | |
| 0.025 | 0.565 | 0.184 | DNA polymerase I inhibitor | 0.172 0.038 DBMET03399 0.18 0.035 DBMET03400 0.184 0.034 DBMET03401 | DBMET03401 | |
| 0.025 | 0.573 | 0.091 | Nav1.1 sodium channel blocker | 0.091 0.078 DBMET03394 | DBMET03394 | |
| 0.019 | 0.608 | 0.091 | Adenine nucleotide translocase inhibitor | 0.076 0.011 DBMET03399 0.076 0.011 DBMET03400 0.091 0.005 DBMET03401 | DBMET03401 | |
| 0.005 | 0.612 | 0.037 | Liver X receptor alpha antagonist | 0.037 0.011 DBMET03396 | DBMET03396 | |
| 0.01 | 0.671 | 0.11 | Acetylcholine antagonist | 0.11 0.08 DBMET03394 | DBMET03394 | |
| 0.01 | 0.674 | 0.113 | Cholinergic antagonist | 0.113 0.081 DBMET03394 | DBMET03394 | |
| 0.012 | 0.684 | 0.205 | Hypolipemic | 0.161 0.127 DBMET03396 0.205 0.09 DBMET03397 | DBMET03397 | |
| 0.007 | 0.709 | 0.103 | Acetylcholine muscarinic antagonist | 0.103 0.088 DBMET03394 | DBMET03394 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |